Alivexis
Latest round
- Series D
Last raised
- Jan 2025
Total raised
- $62M
Investors
- 17
About Alivexis
Alivexis, Inc.Founded in 2016 in Tokyo, Japan, Alivexis, Inc. specializes in data analytics and software development aimed at enhancing decision-making processes.Alivexis, Inc. specializes in advanced data analytics and software solutions aimed at enhancing decision-making processes within various industries. The company's core offerings include proprietary analytical tools designed to process and visualize complex datasets, enabling clients to derive actionable insights. These products cater to a diverse clientele, including financial institutions, healthcare organizations, and technology firms, all seeking to improve operational efficiency and strategic planning. Modulus Discovery's services are particularly valuable in the realms of risk assessment, market analysis, and predictive modeling, addressing critical needs for accurate forecasting and data-driven decision-making.Modulus Discovery operates on a subscription-based revenue model, offering clients access to its suite of analytical tools and services through tiered pricing plans. Clients engage with the company under contractual agreements that may include annual subscriptions or project-based fees, depending on the scope of services required. The flagship products are designed to facilitate both B2B and direct-to-consumer transactions, allowing organizations to leverage data insights for competitive advantages. Revenue generation is supported by partnerships with key industry players, further enhancing the company's market presence and service delivery capabilities. The company plans to accelerate its existing pipeline of over 10 R&D programs. Additionally, Modulus Discovery is targeting new geographic markets for expansion, which will be detailed in upcoming product releases. These initiatives are expected to enhance the company's capabilities and market reach.
Who invested in Alivexis
17 investors across 5 rounds
See all investors in Alivexis
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Alivexis
Who invested in Alivexis?
Alivexis has 17 investors on record across 5 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Alivexis raised?
Alivexis has raised 5 venture rounds. Sign up free to see how much each round raised and the total.
When did Alivexis last raise money?
Alivexis's most recent round on record is a Series D, in Jan 2025.
What does Alivexis do?
Alivexis is a pharmaceuticals company.
Where is Alivexis headquartered?
Alivexis is headquartered in Tokyo, Japan.
Which VCs invest in companies like Alivexis?
Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Hui Hua Fund, Yufu Capital and ICBC Capital Management back pharmaceuticals companies at Alivexis's stage. Their profiles are linked below.
VCs backing pharmaceuticals startups at Series D
Raising like Alivexis? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.